Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (PRLD)

CUSIP: 74065P101

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
65,427,364
Total 13F shares
33,322,061
Share change
+33,322,061
Total reported value
$999,836,330
Price per share
$30.13
Number of holders
38
Value change
+$999,836,330
Number of buys
38

Quarterly Holders Quick Answers

What is CUSIP 74065P101?
CUSIP 74065P101 identifies PRLD - Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of PRLD - Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (PRLD) as of Q3 2020

As of 30 Sep 2020, Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (PRLD) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,322,061 shares. The largest 10 holders included ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, FMR LLC, HILLHOUSE CAPITAL ADVISORS, LTD., UBS ASSET MANAGEMENT AMERICAS INC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, PRICE T ROWE ASSOCIATES INC /MD/, Rock Springs Capital Management LP, SUVRETTA CAPITAL MANAGEMENT, LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 38 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2020 vs Q4 2025 Across Filers

Q4 2025 holders
48
Q3 2020 holders
38
Holder diff
-10
Investor Q4 2025 Shares Q3 2020 Shares Share Diff Share Chg % Q4 2025 Value $ Q3 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .